DROPERIDOL
2.5 mg/mL · Injection Solution
By Hikma Pharmaceuticals USA Inc.
- NDC
- 0143-9514
- Route
- Intramuscular; Intravenous
- Therapeutic class
- Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist
- Marketing category
- ANDA
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

